Donor characteristics affecting cell content in PBSC grafts (n = 312)
| Donor characteristics . | CD34+ . | DC2 . | ||
|---|---|---|---|---|
| Estimate* (SE) . | P . | Estimate* (SE) . | P . | |
| Statin therapy | −0.78 (0.48) | .11 | −1.46 (0.46) | .002 |
| Age (per 10 y) | −.56 (0.18) | .002 | 0.66 (0.16) | < .001 |
| Female sex | −1.69 (0.34) | < .001 | 0.14 (0.32) | .65 |
| Donor characteristics . | CD34+ . | DC2 . | ||
|---|---|---|---|---|
| Estimate* (SE) . | P . | Estimate* (SE) . | P . | |
| Statin therapy | −0.78 (0.48) | .11 | −1.46 (0.46) | .002 |
| Age (per 10 y) | −.56 (0.18) | .002 | 0.66 (0.16) | < .001 |
| Female sex | −1.69 (0.34) | < .001 | 0.14 (0.32) | .65 |
Effect on cell dose estimated from multiple regression model; units are 106 cells per kilogram.